Literature DB >> 19295630

Cross-regulation of signaling by ITAM-associated receptors.

Lionel B Ivashkiv1.   

Abstract

An important function of receptors that signal through immunoreceptor tyrosine-based activation motifs (ITAMs) is to regulate signaling by heterologous receptors. This review describes mechanisms by which ITAM-associated receptors modulate signaling by Toll-like receptors (TLRs), tumor necrosis factor receptor family members and cytokine receptors that use the Jak-STAT signaling pathway, and the biological importance of this signal transduction cross-talk. ITAM-mediated cross-regulation can either augment or dampen signaling by other receptors. Conversely, TLRs and cytokines modulate ITAM-mediated signaling, by means including activation of beta2 integrins that are coupled to the ITAM-containing adaptors DAP12 and FcRgamma. Integration of ITAM signaling into signaling networks through cross-talk with other signal transduction pathways results in tight regulation and fine tuning of cellular responses to various extracellular stimuli and contributes to induction of specific activation and differentiation pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295630      PMCID: PMC2753670          DOI: 10.1038/ni.1706

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  97 in total

1.  Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.

Authors:  A Takaoka; N Tanaka; Y Mitani; T Miyazaki; H Fujii; M Sato; P Kovarik; T Decker; J Schlessinger; T Taniguchi
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.

Authors:  Benoit Pasquier; Pierre Launay; Yutaka Kanamaru; Ivan C Moura; Séverine Pfirsch; Claude Ruffié; Dominique Hénin; Marc Benhamou; Marina Pretolani; Ulrich Blank; Renato C Monteiro
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

3.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Authors:  Neil C Rogers; Emma C Slack; Alexander D Edwards; Martijn A Nolte; Oliver Schulz; Edina Schweighoffer; David L Williams; Siamon Gordon; Victor L Tybulewicz; Gordon D Brown; Caetano Reis e Sousa
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

4.  Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12.

Authors:  Jessica A Hamerman; Nadia K Tchao; Clifford A Lowell; Lewis L Lanier
Journal:  Nat Immunol       Date:  2005-05-15       Impact factor: 25.606

Review 5.  Negative regulation of toll-like receptor-mediated immune responses.

Authors:  Foo Y Liew; Damo Xu; Elizabeth K Brint; Luke A J O'Neill
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

6.  Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway.

Authors:  Zhimei Du; Yuhong Shen; Wentian Yang; Ingrid Mecklenbrauker; Benjamin G Neel; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

7.  ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus.

Authors:  Mark Lucas; Xia Zhang; Vikram Prasanna; David M Mosser
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

8.  Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.

Authors:  Serge Nataf; Adrienne Anginot; Carine Vuaillat; Luc Malaval; Nassima Fodil; Emmanuel Chereul; Jean-Baptiste Langlois; Christiane Dumontel; Gaelle Cavillon; Christian Confavreux; Marlène Mazzorana; Laurence Vico; Marie-Franaçoise Belin; Eric Vivier; Elena Tomasello; Pierre Jurdic
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

9.  Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes.

Authors:  Yi Liu; Emi Masuda; Marissa C Blank; Kyriakos A Kirou; Xiaoni Gao; Mee-Soon Park; Luminita Pricop
Journal:  J Leukoc Biol       Date:  2005-02-09       Impact factor: 4.962

10.  DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis.

Authors:  Isaiah R Turnbull; Jonathan E McDunn; Toshiyuki Takai; R Reid Townsend; J Perren Cobb; Marco Colonna
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

View more
  105 in total

1.  IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.

Authors:  James M Kelley; Paul A Monach; Chuanyi Ji; Yebin Zhou; Jianming Wu; Sumiaki Tanaka; Alfred D Mahr; Sharleen Johnson; Carol McAlear; David Cuthbertson; Simon Carette; John C Davis; Paul F Dellaripa; Gary S Hoffman; Nader Khalidi; Carol A Langford; Phillip Seo; E William St Clair; Ulrich Specks; John H Stone; Robert F Spiera; Steven R Ytterberg; Peter A Merkel; Jeffrey C Edberg; Robert P Kimberly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

2.  A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.

Authors:  Wenfeng Tan; Hui Wu; Jian Zhao; Lezlie A Derber; David M Lee; Nancy A Shadick; Doyt L Conn; Edwin A Smith; Vivian H Gersuk; Gerald T Nepom; Larry W Moreland; Daniel E Furst; Susan D Thompson; Beth L Jonas; V Michael Holers; David N Glass; Pojen P Chen; S Louis Bridges; Michael E Weinblatt; Harold E Paulus; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2010-10

3.  Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia.

Authors:  Bettina Linnartz; Jens Kopatz; Andrea J Tenner; Harald Neumann
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

4.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

Review 5.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

6.  Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner.

Authors:  Jayajit Das
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

7.  Heme amplifies the innate immune response to microbial molecules through spleen tyrosine kinase (Syk)-dependent reactive oxygen species generation.

Authors:  Patricia L Fernandez; Fabianno F Dutra; Letícia Alves; Rodrigo T Figueiredo; Diego Mourão-Sa; Guilherme B Fortes; Sophie Bergstrand; David Lönn; Ricardo R Cevallos; Renata M S Pereira; Ulisses G Lopes; Leonardo H Travassos; Claudia N Paiva; Marcelo T Bozza
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 8.  Navigating the network: signaling cross-talk in hematopoietic cells.

Authors:  Iain D C Fraser; Ronald N Germain
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

9.  A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils.

Authors:  Jingjing Li; Melissa A D'Annibale-Tolhurst; Kenneth B Adler; Shijing Fang; Qui Yin; Adam J Birkenheuer; Michael G Levy; Samuel L Jones; Eui Jae Sung; Eleanor C Hawkins; Jeffrey A Yoder; Shila K Nordone
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-06       Impact factor: 6.914

Review 10.  The role of toll-like receptors in rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.